Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Engineering × 1 year × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 1

Interventions

pembrolizumab 219 Cyclophosphamide 218 Specimen Handling 175 fludarabine 154 Magnetic Resonance Spectroscopy 150 Biopsy 130 Nivolumab 118 Carboplatin 92 Radiotherapy 85 Paclitaxel 79 venetoclax 76 Gemcitabine 76 fludarabine phosphate 74 Cisplatin 74 Injections 63 Bevacizumab 60 atezolizumab 55 Dexamethasone 55 Azacitidine 55 Ipilimumab 54 Radiation 53 Fluorouracil 53 Radiosurgery 51 durvalumab 49 Cetuximab 49 Temozolomide 46 Docetaxel 46 Oxaliplatin 42 Cytarabine 40 Rituximab 39

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07366658 2026-01-26

NEUK203-13

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 1 Not yet recruiting

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡